| 5 | 1/1 | 返回列表 |
| 查看: 397 | 回復(fù): 2 | ||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | ||
葬花公子鐵桿木蟲 (著名寫手)
General
|
[求助]
求賽來(lái)昔布(Celecoxibum)在USP36以上的質(zhì)量標(biāo)準(zhǔn) 已有1人參與
|
|
| 各位大蝦,緊急求助Celecoxibum的最新質(zhì)量標(biāo)準(zhǔn),最好是膠囊或制劑的,原料的EP7.5和USP35的標(biāo)準(zhǔn)我自己就有,USP36的沒(méi)有,求各位幫忙!~ |

金蟲 (正式寫手)

金蟲 (正式寫手)
|
Celecoxib (sel'' e kox' ib). C17H14F3N3O2S 381.4 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; p-[5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide [169590-42-5]. DEFINITION Celecoxib contains NLT 98.0% and NMT 102.0% of C17H14F3N3O2S, calculated on the anhydrous basis. IDENTIFICATION A. Infrared Absorption 197: [Note??Methods 197A, 197K, or 197M under Infrared Absorption may be used. ] [Note??If the spectra obtained show differences, dissolve the substance to be examined and the Reference Standard separately in isopropyl alcohol, evaporate to dryness, and record the new spectra. ] B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. ASSAY Procedure Buffer: 2.7 g/L of monobasic potassium phosphate adjusted with phosphoric acid to a pH of 3.0 ?? 0.2 Mobile phase: Methanol, acetonitrile, and Buffer (3:1:6) Diluent: Methanol and water (3:1) System suitability solution: 0.5 mg/mL of USP Celecoxib RS and 2.4 ??/mL each of USP Celecoxib Related Compound A RS and USP Celecoxib Related Compound B RS in Diluent Standard solution: 0.5 mg/mL of USP Celecoxib RS in Diluent Sample solution: 0.5 mg/mL of Celecoxib in Diluent Chromatographic system (See Chromatography 621, System Suitability.) Mode: LC Detector: UV 215 nm Column: 4.6-mm ?? 25-cm; 5-?? packing L11 Column temperature: 60 Flow rate: 1.5 mL/min Injection size: 25 L Run time: About 1.5 times the celecoxib peak elution System suitability Samples: System suitability solution and Standard solution Suitability requirements Resolution: NLT 1.8 between celecoxib related compound A and celecoxib and NLT 1.8 between celecoxib and celecoxib related compound B, System suitability solution Relative standard deviation: NMT 0.73%, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of C17H14F3N3O2S in the portion of Celecoxib taken: Result = (rU/rS) ?? (CS/CU) ?? 100 rU = = peak response from the Sample solution rS = = peak response from the Standard solution CS = = concentration of the Standard solution (mg/mL) CU = = concentration of the Sample solution (mg/mL) Acceptance criteria: 98.0%?C102.0% on the anhydrous basis IMPURITIES Inorganic Impurities Heavy Metals: NMT 20 ppm Diluent: Acetone and water (17:3) Standard solution: Dilute 1.0 mL of Standard Lead Solution, prepared as directed under Heavy Metals 231, Special Reagents, with Diluent to 20 mL. Sample solution: Dissolve 0.50 g of Celecoxib in 20 mL of Diluent. Blank solution: 20 mL of Diluent Analysis Samples: Standard solution, Blank solution, and Sample solution To each solution, add 2 mL of pH 3.5 Acetate Buffer, prepared as directed under Heavy Metals 231, Method I. Mix, and add to each solution 1.2 mL of thioacetamide?Cglycerin base TS. Mix immediately, and allow to stand for 2 min. Pass the solutions through a filter of 0.45-?? pore size. Compare the spots on the filters obtained from each of the solutions. Acceptance criteria: The brownish-black color of the spot resulting from the Sample solution is not more intense than that of the spot resulting from the Standard solution. The test is invalid if the Standard solution does not show a brownish-black color compared to the Blank solution. Residue on Ignition 281: NMT 0.2%, using a platinum crucible Organic Impurities Procedure Buffer, Mobile phase, Diluent, System suitability solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay. Standard solution: 0.5 ??/mL of USP Celecoxib RS in Diluent System suitability Samples: System suitability solution and Standard solution Suitability requirements Resolution: NLT 1.8 between celecoxib related compound A and celecoxib and NLT 1.8 between celecoxib and celecoxib related compound B, System suitability solution Signal-to-noise ratio: NLT 20, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of each impurity in the portion of Celecoxib taken: Result = (rU/rS) ?? (CS/CU) ?? 100 rU = = peak response for each impurity in the Sample solution rS = = peak response of celecoxib in the Standard solution CS = = concentration of celecoxib in the Standard solution (mg/mL) CU = = concentration of Celecoxib in the Sample solution (mg/mL) Acceptance criteria Individual impurities: See Table 1. [Note??Disregard any impurity peak less than 0.05%. ] Table 1 Name Relative Retention Time Acceptance Criteria, NMT (%) Celecoxib related compound Aa 0.9 0.4 Celecoxib 1.0 ?? Celecoxib related compound Bb 1.1 0.10 Individual unspecified impurity ?? 0.10 Total impurities ?? 0.5 a 4-[5-(3-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. b 4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. SPECIFIC TESTS Water Determination, Method I 921: NMT 0.5%, using a 400-mg sample ADDITIONAL REQUIREMENTS Packaging and Storage: Preserve in tight containers, protected from light and moisture. Store at room temperature. USP Reference Standards 11 USP Celecoxib RS p-[5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide. C17H14F3N3O2S 381.4 USP Celecoxib Related Compound A RS 4-[5-(3-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. C17H14F3N3O2S 381.4 USP Celecoxib Related Compound B RS 4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. C17H14F3N3O2S 381.4 Auxiliary Information?? Please check for your question in the FAQs before contacting USP. Topic/Question Contact Expert Committee Monograph Hillary Z Cai Scientific Liaison, Small Molecules (301) 230-3379 (SM22010) Monographs - Small Molecules 2 Reference Standards RS Technical Services 1-301-816-8129 rstech@usp.org USP37?CNF32 Page 2246 Pharmacopeial Forum: Volume No. 36(6) Page 1519 Chromatographic Column?? CELECOXIB Chromatographic columns text is not derived from, and not part of, USP 37 or NF 32. |

| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 085602 化工專碩 338分 求調(diào)劑 +8 | 路癡小琪 2026-03-27 | 8/400 |
|
|---|---|---|---|---|
|
[考研] 安徽大學(xué)專碩生物與醫(yī)藥專業(yè)(086000)324分,英語(yǔ)已過(guò)四六級(jí),六級(jí)521,求調(diào)劑 +4 | 美味可樂(lè)雞翅 2026-03-26 | 4/200 |
|
|
[考研] 265求調(diào)劑 +4 | 小木蟲085600 2026-03-27 | 4/200 |
|
|
[考研] 329求調(diào)劑 +4 | 星野? 2026-03-26 | 4/200 |
|
|
[考研] 考研調(diào)劑 +9 | 小蠟新筆 2026-03-26 | 9/450 |
|
|
[考研] 276求調(diào)劑。有半年電池和半年高分子實(shí)習(xí)經(jīng)歷 +10 | 材料學(xué)257求調(diào)劑 2026-03-23 | 11/550 |
|
|
[考研] 316求調(diào)劑 +5 | 江辭666 2026-03-26 | 5/250 |
|
|
[考研] 324求調(diào)劑 +8 | hanamiko 2026-03-26 | 10/500 |
|
|
[考研]
|
nnnnnnn5 2026-03-25 | 5/250 |
|
|
[考研] 調(diào)劑求收留 +7 | 果然有我 2026-03-26 | 7/350 |
|
|
[考研] 336材料求調(diào)劑 +7 | 陳瀅瑩 2026-03-26 | 9/450 |
|
|
[考研] 327求調(diào)劑 +7 | prayer13 2026-03-23 | 7/350 |
|
|
[考研] 329求調(diào)劑 +5 | 1() 2026-03-22 | 5/250 |
|
|
[考研] 0703化學(xué)求調(diào)劑 +3 | 丹青奶蓋 2026-03-26 | 5/250 |
|
|
[考研] 一志愿北京化工大學(xué)材料與化工(085600)296求調(diào)劑 +9 | 稻妻小編 2026-03-26 | 9/450 |
|
|
[考研] 環(huán)境專碩324分求調(diào)劑推薦 +5 | 軒小寧—— 2026-03-26 | 5/250 |
|
|
[考研] 318求調(diào)劑 +3 | plum李子 2026-03-23 | 3/150 |
|
|
[考研] 336求調(diào)劑 +4 | 收到VS 2026-03-20 | 4/200 |
|
|
[考研] 297求調(diào)劑 +3 | 喜歡還是不甘心 2026-03-20 | 3/150 |
|
|
[考研] 0805材料320求調(diào)劑 +3 | 深海物語(yǔ) 2026-03-20 | 3/150 |
|